F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Camrelizumab

Page 1 of 1 ( 11 items )
<<
1
>>

1	Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy 8/7/2025 6:39:58 AM \| Browse: 147 \| Download: 447
2	Advanced pancreatic cancer treated with camrelizumab combined with apatinib: A case report 1/18/2025 8:12:11 AM \| Browse: 125 \| Download: 626
3	Five-year complete remission of super-giant hepatocellular carcinoma with hepatectomy followed by sorafenib plus camrelizumab: A case report 12/27/2024 1:37:06 PM \| Browse: 176 \| Download: 771
4	TRIPLET combined with microwave ablation: A novel treatment for advanced hepatocellular carcinoma 12/12/2024 9:30:52 AM \| Browse: 196 \| Download: 592
5	Dermatitis bullosa caused by the immune checkpoint inhibitor camrelizumab: A case report 12/4/2024 8:24:11 AM \| Browse: 168 \| Download: 696
6	Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy 9/26/2024 8:22:28 AM \| Browse: 159 \| Download: 745
7	Impact of baseline hepatitis B virus viral load on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy 6/15/2024 2:49:03 AM \| Browse: 216 \| Download: 1118
8	Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports 9/29/2022 9:17:29 AM \| Browse: 622 \| Download: 1533
9	Camrelizumab-induced anaphylactic shock in an esophageal squamous cell carcinoma patient: A case report and review of literature 6/17/2022 3:19:27 AM \| Browse: 484 \| Download: 1672
10	Successful response to camrelizumab in metastatic bladder cancer: A case report 12/30/2021 8:21:53 AM \| Browse: 624 \| Download: 1458
11	Camrelizumab (SHR-1210) leading to reactive capillary hemangioma in gingiva: A case report 2/6/2020 2:37:44 AM \| Browse: 790 \| Download: 1580

Page 1 of 1 ( 11 items )
<<
1
>>

Write to the Help Desk

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.